Erschienen in:
16.09.2023 | Insight
Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α in the Spotlight with Multiple Sclerosis
verfasst von:
Ya-Na Yang, Mao-Qing Zhang, Feng-Lin Yu, Bing Han, Ming-Yue Bao, Yan He, Xing Li, Yuan Zhang
Erschienen in:
Neuroscience Bulletin
|
Ausgabe 2/2024
Einloggen, um Zugang zu erhalten
Excerpt
Multiple sclerosis (MS) is a chronic and incurable autoimmune disease of the central nervous system (CNS) that results in neuro-inflammation and demyelination. Current therapies for MS alleviate symptoms to some extent but fail to realize myelin regeneration. Hence, it is crucial to identify effective targets to promote remyelination. As a widely expressed transcriptional regulator, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) expresses in different cells with high energy consumption, including skeletal muscle cells, brown fat cells, neurons, astrocytes, and oligodendrocyte precursor cell (OPC) [
1]. Targeting PGC-1α may be beneficial for CNS development and various neurodegenerative diseases. …